Phio Pharmaceuticals Corp (PHIO)

[Inoviorulez]

Smart decision. I should have sold when Tang Capital sold. AT the time I didn't understand why, but now I do. It all makes sense

The added cohorts on scarring because the drug doesn't work as well on scarring

The small purchases by the CEO 5,000 shares here and there. No other purchases by directors at all.

The CSO Pamela Pavco resigning in the middle of scar trials. She took a backseat to the board instead collecting money.

No meaningful scar pictures or data in over 2 years at all. At first they showed photos and data, then in 2 years they kept quiet on added cohorts. Leads me to believe scar trial is a failure. They will say we need to add more cohorts but we see positive effect and that's it no data released.

AMD program taking forever they bought wet AMD bevasirinib from OPKO and did nothing with it

They made a supposed partnership with a no name company for Lou Gherig's disease that went nowhere

What happened to the retinoblastoma program they started with the children's hospital? Heard nothing about that since few years ago?

What about the other targets they could have gone for that were better like lung fibrosis etc.?

Just too many red flags and I hope investors reading this avoid this company at all costs. There are better biotech companies with management teams that care about their shareholders. This management has already gone through many reverse splits and the share price has tanked 99% each time. Avoid at all costs